Company
Metagenomi Therapeutics, Inc.
MGX · CIK 0001785279
Purchase of 19,883 shares at $1.17 per share.
Reporting Person Reid Laurence · Transaction Code P
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389550 · filed 2026-09-11 · View filing →
Purchase of 117 shares at $1.18 per share.
Reporting Person Reid Laurence · Transaction Code P
Traded Sep 9, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001193125-26-389550 · filed 2026-09-11 · View filing →
Sale of 1,911 shares at $1.1584 per share.
Reporting Person Wapnick Pamela · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001193125-26-387786 · filed 2026-09-10 · View filing →
Sale of 2,140 shares at $1.1584 per share.
Reporting Person Irish Jian · Officer Title See Remarks · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001193125-26-387798 · filed 2026-09-10 · View filing →
Sale of 358 shares at $1.1584 per share.
Reporting Person Wein Matthew · Officer Title See Remarks · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 10, 2026
Source: SEC Form 4 · 0001193125-26-387816 · filed 2026-09-10 · View filing →